Financial results - CABINET ONCOLOGIE ONCOMAX S.R.L.

Financial Summary - Cabinet Oncologie Oncomax S.r.l.
Unique identification code: 45924788
Registration number: J10/464/2022
Nace: 8622
Sales - Ron
18.262
Net Profit - Ron
1.572
Employees
1
Open Account
Company Cabinet Oncologie Oncomax S.r.l. with Fiscal Code 45924788 recorded a turnover of 2024 of 18.262, with a net profit of 1.572 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Cabinet Oncologie Oncomax S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 14.081 31.141 18.262
Total Income - EUR - - - - - - - 14.121 31.158 18.275
Total Expenses - EUR - - - - - - - 11.927 24.098 15.986
Gross Profit/Loss - EUR - - - - - - - 2.194 7.060 2.289
Net Profit/Loss - EUR - - - - - - - 1.771 5.634 1.572
Employees - - - - - - - 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -41.0%, from 31.141 euro in the year 2023, to 18.262 euro in 2024. The Net Profit decreased by -4.031 euro, from 5.634 euro in 2023, to 1.572 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Cabinet Oncologie Oncomax S.r.l.

Rating financiar

Financial Rating -
CABINET ONCOLOGIE ONCOMAX S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Cabinet Oncologie Oncomax S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cabinet Oncologie Oncomax S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Cabinet Oncologie Oncomax S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cabinet Oncologie Oncomax S.r.l. - CUI 45924788

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 25 2.807 1.753
Current Assets - - - - - - - 3.870 6.478 6.951
Inventories - - - - - - - 144 539 588
Receivables - - - - - - - 432 4.571 5.075
Cash - - - - - - - 3.294 1.367 1.287
Shareholders Funds - - - - - - - 1.811 5.683 1.539
Social Capital - - - - - - - 41 40 40
Debts - - - - - - - 2.083 3.602 7.165
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 6.951 euro in 2024 which includes Inventories of 588 euro, Receivables of 5.075 euro and cash availability of 1.287 euro.
The company's Equity was valued at 1.539 euro, while total Liabilities amounted to 7.165 euro. Equity decreased by -4.112 euro, from 5.683 euro in 2023, to 1.539 in 2024.

Risk Reports Prices

Reviews - Cabinet Oncologie Oncomax S.r.l.

Comments - Cabinet Oncologie Oncomax S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.